Why the study?
Does ceforanide reduce postoperative infections compared to cephalothin in patients undergoing cardiovascular surgery?
Does ceforanide reduce postoperative infections compared to cephalothin in patients undergoing cardiovascular surgery?
Ceforanide is superior to cephalothin as perioperative antibiotic prophylaxis for preventing infections after coronary artery bypass surgery.
Answers are grounded in this paper and cite their sources.
Supports ceforanide over cephalothin for CABG prophylaxis; extends RCT evidence on optimal perioperative antibiotics.
Two hundred twenty patients were randomly assigned to receive either ceforanide or cephalothin as perioperative antibiotic prophylaxis during cardiovascular surgery. More infections were seen among cephalothin recipients (8 deep, 32 total) than among ceforanide recipients (1 deep, 17 total). Among patients who had only coronary artery bypass grafting, more cephalothin recipients had infection than did ceforanide recipients (19 of 82 as opposed to 7 of 83; p = 0.001; relative risk, 2.7; 95% confidence interval, 1.22 to 6.18). The difference between the two regimens was attributable to fewer blood, wound, and urinary tract infections. Among patients who had other procedures, there was no difference in the efficacy of the two regimens. Cephalothin recipients who developed wound or blood stream infections had lower antibiotic levels in their atrial appendages than recipients not developing such infections (p = 0.02). If one assumes that cephalothin does not increase the risk of infection, then these data show that antibiotic prophylaxis prevents infection after coronary artery bypass surgery, and, in the dosages used, that ceforanide is superior to cephalothin.
No takes yet. Share an insight, caveat, or question.
Richard Platt (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: